A Novel

Chenyang Xu, Zhipeng Nie, Suyang Wang, Yiming Zhu, Xiaowen Liu, Yufen Guo

Abstract read

In one paragraph

Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

A NovelHuman mutation · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenyang XuThe Second Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China, lzu.edu.cn.ORCID https://orcid.org/0009-0001-1286-0820

Zhipeng NieCenter for Mitochondrial Biomedicine and Department of Ophthalmology, Zhejiang University School of Medicine, Zhejiang, China, zju.edu.cn.ORCID https://orcid.org/0009-0009-0863-1126

Suyang WangThe Second Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China, lzu.edu.cn.ORCID https://orcid.org/0009-0000-7478-2621

Yiming ZhuDepartment of Otolaryngology-Head and Neck Surgery, Gansu Provincial Hospital, Lanzhou, Gansu, China, gsyy.cn.ORCID https://orcid.org/0009-0002-2615-5089

Xiaowen LiuThe Second Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China, lzu.edu.cn.ORCID https://orcid.org/0009-0003-0246-1775

Yufen GuoThe Second Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China, lzu.edu.cn.ORCID https://orcid.org/0009-0009-2619-8530

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenic variants in the LIM-homeodomain transcription factor

Indexed as

Frameshift MutationHearing Loss, SensorineuralLIM-Homeodomain ProteinsTranscription FactorsExome SequencingFemaleGenetic Predisposition to DiseaseHeterozygoteHumansMalePedigreePhenotypeLIM-Homeodomain ProteinsLMX1A protein, humanTranscription Factorsasymmetric sensorineural hearing lossauditory homeostasiscochlear aperture stenosisLMX1Atranscriptional activity

Identifiers

PMID42253511

DOI10.1155/humu/9930672

PMCPMC13240465

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.